文献速递妇科

输卵管内膜异位症与妇科恶性肿瘤的相关性

The association of endosalpingiosis with gynecologic malignancy.
PubMed 文献 · Gynecol Oncol · 2022-07-29

回顾性病例对照研究纳入2000至2020年三家附属学术医院967例组织学诊断输卵管内膜异位症或子宫内膜异位症患者,比较两组妇科恶性肿瘤发生情况。输卵管内膜异位症组手术时癌症诊断率显著高于子宫内膜异位症组,多变量分析显示癌症诊断风险及死亡风险增加。

要点

  • 输卵管内膜异位症患者手术时癌症诊断率40.1%,显著高于子宫内膜异位症组的18.1%。
  • 排除已知或疑似恶性肿瘤后,两组癌症诊断率差异仍显著(20.9% vs 5.6%)。
  • 多变量分析显示输卵管内膜异位症与手术时癌症诊断(OR=2.48)及死亡风险(OR=1.69)增加相关。

核心结论

  • 输卵管内膜异位症在40%的病例中与恶性肿瘤同时存在,该效应在多变量分析和亚组分析中保持不变。
  • 作者认为需要进一步研究,包括更长的随访和探索输卵管内膜异位症与癌症之间的分子关系。

研究设计与样本

  • 回顾性病例对照分析,纳入2000年至2020年三家附属学术医院组织学诊断输卵管内膜异位症或子宫内膜异位症的患者。
  • 所有输卵管内膜异位症患者均纳入,尝试1:1匹配以获得可比的子宫内膜异位症队列,共纳入967例患者(515例输卵管内膜异位症和452例子宫内膜异位症)。

主要发现

  • 输卵管内膜异位症组患者年龄显著大于子宫内膜异位症组(中位年龄52岁 vs 48岁,p < 0.001)。
  • 输卵管内膜异位症组手术时癌症诊断率显著高于子宫内膜异位症组(40.1% vs 18.1%,p < 0.001),排除已知或疑似恶性肿瘤患者的亚组分析中差异持续存在(20.9% vs 5.6%,p < 0.001)。
  • 输卵管内膜异位症组总生存较低(10年无死亡生存率:77.0% vs 90.5%,p < 0.001)。
  • 调整混杂因素后,多变量分析显示输卵管内膜异位症患者手术时癌症诊断增加(OR = 2.48,p < 0.001),死亡风险增加(OR = 1.69,p = 0.017)。

局限性

  • 原文报告需要进一步研究,包括更长的随访和探索输卵管内膜异位症与癌症之间的分子关系。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Endosalpingiosis is a poorly understood condition of ectopic epithelium resembling the fallopian tubes. It has been described as an incidental pathology finding, a disease similar to endometriosis, and in association with malignancy. The objective of this study is to determine if endosalpingiosis (ES) has an increased association with gynecologic malignancy when compared to endometriosis (EM). METHODS: This is a retrospective case-control analysis of patients with a histologic diagnosis of endosalpingiosis or endometriosis at three affiliated academic hospitals between 2000 and 2020. All ES patients were included, and 1:1 matching was attempted to obtain a comparable cohort of EM patients. Demographic and clinical data were obtained, and statistical analysis was performed. RESULTS: A total of 967 patients (515 ES and 452 EM) were included. ES patients were significantly older than EM patients (median age 52 vs 48 years, p < 0.001). The ES group had significantly more cancer diagnoses at surgery than the EM group (40.1% vs 18.1%, p < 0.001); this difference persisted in a sub-analysis excluding patients with known or suspected malignancy (20.9% vs 5.6%, p < 0.001). ES patients had lower overall survival (10-year freedom from death: 77.0% vs 90.5%, p < 0.001). After adjusting for confounders, multivariable analysis showed that ES patients had increased cancer diagnosed at surgery (OR = 2.48, p < 0.001) and greater risk of death (OR = 1.69, p = 0.017). CONCLUSIONS: Endosalpingiosis was found concurrently with malignancy in 40% of cases, and this effect was preserved in multi-variable and sub-group analyses. Further research consisting of longer follow-up and exploration of molecular relationships between ES and cancer are forthcoming.

来源:Gynecol Oncol,查看原文。版权归原作者所有。

引用

  1. Lewis GK, Ghaith S, Craver EC, et al. The association of endosalpingiosis with gynecologic malignancy. Gynecol Oncol. 2022. PMID: 35909004. doi:10.1016/j.ygyno.2022.07.025

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。